PTGX - Protagonist Therapeutics Inc
IEX Last Trade
42.92
0.630 1.468%
Share volume: 497,253
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$42.29
0.63
1.49%
Summary score
22%
Profitability
25%
Dept financing
9%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-15%
Return on assets
-10.87%
Return on sales
0%
Return on invested capital
36.55%
Total debt ratio
26.43%
Debt ratio change over timeo
-0.38%
Current Ratio
6.33%
Quick Ratio
0%
Cash Position Ratio
3.21%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-20.68%
Return on assets
-11.43%
Return on sales
0%
Return on invested capital
73.89%
Total debt ratio
41.56%
Debt ratio change over timeo
-0.5%
Current Ratio
4.6%
Quick Ratio
0%
Cash Position Ratio
2.09%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-11.6%
Return on assets
-8.19%
Return on sales
0%
Return on invested capital
69.74%
Total debt ratio
25.56%
Debt ratio change over time
-0.65%
Current Ratio
6.15%
Quick Ratio
0%
Cash Position Ratio
4.14%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-121.62%
Return on assets
-115.7%
Return on sales
0%
Return on invested capital
-19.47%
Total debt ratio
-38.08%
Debt ratio change over time
-0.38%
Current Ratio
9.46%
Quick Ratio
0%
Cash Position Ratio
4.81%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PTGX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -15% | -3.05% | 11.55% | 6.27% |
| Return on assets | -10.87% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 36.55% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 40% | 72% | 67% |
| Total debt ratio | 26.43% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.38% | 6.09% | 6.03% | 1.53% |
| Dept financing | 7% | 50% | 43% | 14% |
| Current Ratio | 4.6% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.09% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 22% | 44% | 47% |
| Short-term ratios | PTGX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -20.68% | -25.62% | 17.94% | 7.14% |
| Return on assets | -11.43% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 73.89% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 41% | 72% | 63% |
| Total debt ratio | 41.56% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.5% | -23.44% | 9.66% | 0.6% |
| Dept financing | 10% | 25% | 45% | 8% |
| Current Ratio | 4.6% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.09% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 46% | 35% | 62% |